A Randomized, Double-Blind, Placebo- and Active-Controlled, 4-Period Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects
Phase of Trial: Phase I
Latest Information Update: 02 May 2017
At a glance
- Drugs Lemborexant (Primary) ; Zopiclone
- Indications Insomnia
- Focus Pharmacodynamics
- Sponsors Eisai Inc
- 27 Mar 2017 Status changed from recruiting to completed.
- 17 Dec 2016 Planned End Date changed from 1 Dec 2016 to 1 Feb 2017.
- 17 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Jan 2017.